Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksASPIRA
resources
ASPIRA

Aspira Pathlab & Diagnostics Ltd.

BSE: 540788
Sector: Healthcare
Industry Group: Healthcare Services
106.90-2.1 (-1.97%)
7 Aug, 12:00 AM

Annual Reports and Financial Documents

Aspira Pathlab & Diagnostics Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025—
Quarterly Results—————
Conference Calls——————————————
Presentations——————————————

Corporate Announcements and Regulatory Filings

Aspira Pathlab & Diagnostics Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • Board Meeting6 Aug 2026
    Board Meeting Intimation for Approval Of Un-Audited Financial Result (Standalone) For The First Quarter Ended On June 30,2026 And To Transact Other Businesses
    Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve 1.Unaudited Financial ....
  • General3 Aug 2026
    Resignation Of Internal Auditor
    Enclosed herewith Resignation of M/s Vishal J Bhanushali and Associated with effect from 13th August 2026
  • Resignation of Chief Executive Officer (CEO)3 Aug 2026
    Announcement under Regulation 30 (LODR)-Resignation of Chief Executive Officer (CEO)
    Enclosed herewith Resignation of Mr. Pankaj Jashwant Shah from post of Managing Director and Chief Executive Officer with effect from 03.08.2026
  • Resignation of Managing Director3 Aug 2026
    Announcement under Regulation 30 (LODR)-Resignation of Managing Director
    Enclosed herewith Resignation of Mr. Pankaj Jashwant Shah from post of Managing Director cum Chief Executive Officer with effect from 03.08.2026
  • Resignation of Director3 Aug 2026
    Announcement under Regulation 30 (LODR)-Resignation of Director
    Enclosed herewith Resignation of Pankaj jashwant Shah (DIN:02836324)
  • Resignation of Director25 Jul 2026
    Announcement under Regulation 30 (LODR)-Resignation of Director
    Mr. Vaibhav Odhekar has resigned from Company as an Additional Executive Director with effect from close of business hours 25.07.2026
  • Change in Directorate25 Jul 2026
    Announcement under Regulation 30 (LODR)-Change in Directorate
    Resignation of Mr. Vaibhav Odhekar as an Additional Executive Director from Company with effect from close of business hours on 25.07.2026
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201813 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Compliance Certificate in accordance with regulation 74(5) of SEBI (DP) regulation 2018 for quarter ended 30th June 2026
  • Closure of Trading Window24 Jun 2026
    Closure of Trading Window
    Intimation of closure of Trading window for quarter ended 30.06.2026
  • General11 Jun 2026
    Disclosure Under Regulation 30(LODR) For Classification Of Mr. Nikunj Mange And Mr. Jay Arvind Bhanushali As Promoters Of The Company
    Intimation of Classification of Mr. Nikunj Mange and Mr. Jay Arvind Bhanushali as Promoters of the Company Pursuant to Completion of Open Offer
  • Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201111 Jun 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shraddha Bhanushali & PACs
  • Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201111 Jun 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deepali Arvind Bhanushali & PACs
  • Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201111 Jun 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raj Arvind Bhanushali & PACs
  • Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201110 Jun 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali & PACs
  • Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201110 Jun 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nikunj Mange & PACs
  • Reg.24(A)-Annual Secretarial Compliance25 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    The Annual Secretarial Compliance Report for the year ended 31 March 2026 issued by Ms. Prajakta V. Padhye, Partner of Nilesh A. Pradhan & Co. LLP, Practising Company Secretaries, Mumbai
  • Newspaper Publication25 May 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Advertisement for the Financial Result as on 31 March 2026
  • Change in Directorate23 May 2026
    Announcement under Regulation 30 (LODR)-Change in Directorate
    The Board approved the appointment of Mr. Vaibhav Odhekar as an Additional Executive Director for 5 years
  • Appointment of Company Secretary / Compliance Officer23 May 2026
    Appointment of Company Secretary and Compliance Officer
    The disclosure regarding of Mrs. Neetu Maurya as a Company Secretary of the company with effect from 24.05.2026 was inadvertently filed under change in Control
  • Change in Management Control23 May 2026
    Announcement under Regulation 30 (LODR)-Change in Management Control
    Appointment of Mrs. Neetu Maurya as Company Secretary of the Company With Effect From 24.05.2026

Frequently Asked Questions

Where can I download the annual report of Aspira Pathlab & Diagnostics Ltd.?
Annual reports of Aspira Pathlab & Diagnostics Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Aspira Pathlab & Diagnostics Ltd.?
Quarterly earnings results and presentations of Aspira Pathlab & Diagnostics Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Aspira Pathlab & Diagnostics Ltd. publish earnings call transcripts?
Earnings call transcripts of Aspira Pathlab & Diagnostics Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Aspira Pathlab & Diagnostics Ltd.?
Investor presentations and annual day presentations of Aspira Pathlab & Diagnostics Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Aspira Pathlab & Diagnostics Ltd.?
Corporate announcements and regulatory filings of Aspira Pathlab & Diagnostics Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Aspira Pathlab & Diagnostics Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Aspira Pathlab & Diagnostics Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Aspira Pathlab & Diagnostics Ltd.?
The ISIN (International Securities Identification Number) of Aspira Pathlab & Diagnostics Ltd. is INE500C01017. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Aspira Pathlab & Diagnostics Ltd. listed?
Aspira Pathlab & Diagnostics Ltd. is listed on NSE and BSE. The NSE symbol is ASPIRA and the BSE code is -.
Where can I find the shareholding pattern of Aspira Pathlab & Diagnostics Ltd.?
The quarterly shareholding pattern of Aspira Pathlab & Diagnostics Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Aspira Pathlab & Diagnostics Ltd. on Sharpely?
Share price data for Aspira Pathlab & Diagnostics Ltd. is updated as of 7 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.